The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples.
The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider.
Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples.
“InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.”
Astor Apiaries' Nick Hoefly is an expert on honey bees and, of course, honey. Cheddar News' Michelle Castillo checked out the hives to learn everything you ever wanted to know about honey ahead of Bee's Knees Week.
Nick Hoefly of Astor Apiaries explains the importance of bees for our ecosystem and talks to Cheddar News' Michelle Castillo about what you can do if you're nervous around them.
Research now shows dogs tend to age better when they have plenty of interaction with humans and other pets, according to a study published in the journal Evolution, Medicine & Public Health.
Children who lived closer to natural gas wells in heavily drilled western Pennsylvania were more likely to develop a relatively rare form of cancer, and nearby residents of all ages had an increased chance of severe asthma reactions, researchers said in reports released Tuesday evening.
Surgeons transplanted a pig’s kidney into a brain-dead man and for over a month it's worked normally — a critical step toward an operation the New York team hopes to eventually try in living patients.
